In a 13D filing, Bayer's (OTCPK:BAYRY) investment arm disclosed that it sold 632,105 shares of gene editor CRISPR Therapeutics (NASDAQ:CRSP) ...
Source link
In a 13D filing, Bayer's (OTCPK:BAYRY) investment arm disclosed that it sold 632,105 shares of gene editor CRISPR Therapeutics (NASDAQ:CRSP) ...
Source link